摘要
探讨不完全血运重建联合CRT-P治疗老年缺血性心肌病的临床疗效.通过选取90例老年缺血性心肌病患者并随机分为药物组、PCI组与联合组,每组30例.药物组单纯内科药物治疗,PCI组予冠脉介入不完全血运重建治疗,联合组患者不完全血运重建联合CRT-P心脏再同步化治疗.结果表明,联合治疗组患者心功能改善较药物组、PCI组患者明显.差异有统计学意义(P<0.05).研究表明,对老年缺血性心肌病患者采取不完全血运重建联合CRT-P治疗可显著改善患者心功能,不增加心血管事件风险.不完全血运重建联合CRT-P对治疗老年缺血性心肌病具有重要临床意义.
To investigate the clinical effect of incomplete revascularization combined with CRT- P on the treatment of Senile Ischemic cardiomyopathy. 90 cases of senile patients with ischemic cardiomyopathy are randomly divided into drug group,PCI group and combination group,30 cases in each group. Drug group is treated by only drug therapy,PCI group by percutaneous coronary intervention with incomplete revascularization treatment,and combination group by incomplete revascularization combined with CRT- P cardiac resynchronization therapy. The cardiac functions of senile patients with ischemic cardiomyopathy treated by incomplete revascularization combined with CRT- P therapy are significantly improved( P 0. 05),compared with those of the other two groups. Incomplete revascularization combined with CRT- P can improve cardiac functions significantly without causing any risk,which has great clinical significance for the treatment of senile patients with ischemic cardiomyopathy.
出处
《昆明理工大学学报(自然科学版)》
CAS
2016年第4期88-91,共4页
Journal of Kunming University of Science and Technology(Natural Science)
基金
云南省科技厅-昆明医科大学联合专项
关键词
不完全血运
CRT-P
老年缺血性心肌病
incomplete revascularization
CRT-P
senile patients with ischemic cardiomyopathy